These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 3174808

  • 1. Studies on cyclodextrin polymer. Part 1: The effect of CDP on indomethacin tablet formulation.
    Tarimci N, Celebi N.
    Pharmazie; 1988 May; 43(5):323-5. PubMed ID: 3174808
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L, Apostol I, Gerlóczy A, Szejtli J.
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Application of beta-cyclodextrin during direct pressing of tablets].
    Szabóné RP, Pintyéné HK, Kun L, Miseta M, Selmeczi B.
    Acta Pharm Hung; 1989 May; 59(3):99-107. PubMed ID: 2763849
    [Abstract] [Full Text] [Related]

  • 7. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł, Kasperek R, Poleszak E.
    Polim Med; 2014 May; 44(4):231-5. PubMed ID: 25932904
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparative study of modified starches in direct compression of a poorly water soluble drug (hydrochlorothiazide).
    Okafor IS, Ofoefule SI, Udeala OK.
    Boll Chim Farm; 2001 May; 140(1):36-9. PubMed ID: 11338775
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W, Akkaramongkolporn P, Ngawhirunpat T, Rojanarata T, Opanasopit P.
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [Abstract] [Full Text] [Related]

  • 14. Development and optimization of a sublingual tablet formulation for physostigmine salicylate.
    Bolourchian N, Hadidi N, Foroutan SM, Shafaghi B.
    Acta Pharm; 2009 Sep; 59(3):301-12. PubMed ID: 19819826
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion.
    Sammour OA, Hammad MA, Zidan AS, Mowafy AG.
    Pharm Dev Technol; 2011 Jun; 16(3):219-27. PubMed ID: 20163325
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Production and investigating of tablets containing furosemide and beta-cyclodextrin.
    Kata M, Haragh L, Pintye-Hódi K.
    Acta Pharm Hung; 1990 Jan; 60(1):40-5. PubMed ID: 2327256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.